Reuters logo
BRIEF-Harbin Gloria Pharmaceuticals sees H1 2017 net profit down 25-45 pct
April 27, 2017 / 9:42 AM / 7 months ago

BRIEF-Harbin Gloria Pharmaceuticals sees H1 2017 net profit down 25-45 pct

April 27 (Reuters) - Harbin Gloria Pharmaceuticals Co Ltd :

* Sees net profit for H1 2017 to decrease by 25 percent to 45 percent, or to be 194.7 million yuan to 265.5 million yuan, compared to net profit of the same period in 2016 (354 million yuan)

Source text in Chinese: goo.gl/tcF1bM

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below